Budapest, Hungary

András Fehér

This inventor holds 2 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Egis Pharmaceuticals Plc, Femtonics Kft.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: András Fehér. Retrieved from https://idiyas.com/inventor/andrás-fehér

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.5

ph-index = 1


Location History:

  • Budapest, HU (2013)
  • Szekszárd, HU (2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: András Fehér: Innovator in Pharmaceutical Compositions

Introduction

András Fehér is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions for treating acute coronary syndrome.

Latest Patents

Fehér holds a patent for "Prasugrel containing quickly released stable oral pharmaceutical compositions." This invention includes micronized prasugrel base combined with starch or a starch derivative. The patent outlines processes for preparing these compositions and their use in treating atherothrombotic events in patients undergoing percutaneous coronary intervention. He has 1 patent to his name.

Career Highlights

Throughout his career, András Fehér has worked with prominent companies in the pharmaceutical industry. He has been associated with Egis Pharmaceuticals Plc and Egis Gyógyszergyár Zrt., where he contributed to various innovative projects.

Collaborations

Fehér has collaborated with several professionals in his field, including Zsolt Zsigmong and Péter Tonka-Nagy. Their teamwork has likely enhanced the development of his innovative pharmaceutical solutions.

Conclusion

András Fehér's work in pharmaceutical compositions demonstrates his commitment to advancing medical treatments. His contributions are vital for improving patient outcomes in acute coronary syndrome.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…